Eric Lefkofsky And His Company Is Using Data Analytics To Change The World Of Cancer Medicine

Eric Lefkofsky co-founded a company called Tempus Labs and throughout the three years of its existence, it has collaborated with various cancer centers in America. The company is working towards revolutionizing cancer medicine by sequencing data of patients.

In the past, Tempus was featured on a list put together by Dr. Eric Topol. His list includes advances in technology that has appeared in headlines throughout the year. The list features advances that promise to shape and change medicine sometime in the near future.

Tempus Labs made a number of advancements, which is why it earned a mentioned. One of the technologies they’ve been working on is gene editing and gene therapy. These are two bio-technologies that have been used for in what were once thought as un-treatable diseases.

Eric and his company are expected to work towards changing the world of cancer medicine. The motivation behind the company’s work is to provide the care and love cancer patients need during one of the toughest periods of their lives.

Eric Lefkofsky: More About Him

Besides being one of the founders of Tempus, he is a founding partner of a venture fund called Lightbank, whose objective is to invest in disruptive tech. He is also one of the founders of Uptake Technologies. Eric is a serial entrepreneur and businessman who has founded, co-founded or invested in many companies.

Eric Lefkofsky started a foundation in 2006, and it’s called the Lefkofsky Family Foundation. It’s a charitable foundation that he and his wife founded. That’s not the only charitable venture he is involved with. He serves as a trustee of the Art Institute of Chicago, and Laurie Children’s hospital, which is located in Chicago. The businessman studied and graduated from University of Michigan with a Juris Doctor degree. He is also an adjunct professor in Chicago.

For details:

Eric Lefkofsky And His Company Is Using Data Analytics To Change The World Of Cancer Medicine